Cover Image
Market Research Report

Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy ); Allergy Type ; Distribution Channel, and Geography

Published by The Insight Partners Product code 953332
Published Content info 149 Pages
Delivery time: 1-2 business days
Price
Back to Top
Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy ); Allergy Type ; Distribution Channel, and Geography
Published: July 30, 2020 Content info: 149 Pages
Description

Title:
Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)); Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography.

The Allergy Immunotherapies market was valued at US$ million 1,819.18 in 2019 and is projected to reach US$ 4,185.89 million by 2027; it is expected to grow at a CAGR of 11.1% from 2020 to 2027.

The growth of the allergy immunotherapies market is mainly attributed to factors such as growing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, the market is likely to get impacted by the drawbacks associated with the use of allergy immunotherapy and regulatory variations across regions during the forecast period.

Allergy immunotherapy, also called desensitization or hypo-sensitization, is a medical treatment focused on several types of allergies. There is a growth in the prevalence of allergies, and conventional treatment interventions, such as pharmacotherapy, have often been found incompetent. Consequently, allergy immunotherapy is growing popularity for curing several types of allergies by increasing immunological tolerance and changing the course of the disease.

Sublingual immunotherapy (SLIT) is a substitute treatment for allergies without injections. Only the US Food and Drug Administration (FDA)-approved tablets are used for sublingual therapy. However, allergy drops are not FDA approved and are off-label in the US. General sublingual dosage form consists of tablets, film, mini pills, etc., and the advanced formulations include micro particulate spray and atomized liquid. The advanced formulation has a better penetrating ability than the conventional sublingual dosage forms. The capillary network absorbs the drug, forwarding them directly into the bloodstream without entering the gastrointestinal system. The sublingual spray is a modern pharmaceutical administration technology in which the drug can be atomized under the tongue. Atomization facilitates drug diffusion into the capillary network and often acts faster than the other oral administrations. The sublingual spray offers better bioavailability, and so there may be a proven improvement in the onset of therapeutic activity. A range of therapeutically diverse compounds has been formulated as oral sprays by NovaDel using NovaMist technology. NovaMist devices are either breath-actuated pumps or aerosol spray systems containing a drug in liquid formulation and can be supplied in multidose or unidose containers. Thus, a new technology-oriented formulation with multiple benefits drives the growth of the market during the forecast period.

Based on treatment, the market is segmented into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). In 2019, the Subcutaneous Immunotherapy (SCIT) segment held the largest share of the market, by treatment. However, the Sublingual Immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period.

Based on allergy type, the global Allergy Immunotherapies market is segmented into Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others. The Allergic Rhinitis segment held the highest share of the Allergy immunotherapies market in 2019, by Allergy Type. Moreover, the same segment is anticipated to witness growth at a significant rate during the forecast period, 2020 to 2027.

Based on distribution channel, the global Allergy Immunotherapies market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, by Allergy Type. Moreover, the same pharmacy segment is expected to grow at the fastest rate during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), World Allergy Organization, American Academy of Allergy, Asthma & Immunology, and American College of Allergy, are some of the major primary and secondary sources referred for preparing this report.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the allergy immunotherapies market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global allergy immunotherapies market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00008219

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Allergy Immunotherapies Market - By Treatment
    • 1.3.2 Allergy Immunotherapies Market - By Allergy Type
    • 1.3.3 Allergy Immunotherapies Market - By Distribution Channel
    • 1.3.4 Allergy Immunotherapies Market - By Geography

2. Allergy Immunotherapies Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Allergy Immunotherapies Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia-Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Allergy immunotherapies Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Prevalence of Allergic Disorders
    • 5.1.2 Technological Advancements in Sublingual Dosage Formulations
  • 5.2 Key Market Restraint
    • 5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
    • 5.2.2 Regulatory Variations Across Regions
  • 5.3 Key Market Opportunities
    • 5.3.1 Presence of Strong Product Pipeline
  • 5.4 Future Trends
    • 5.4.1 Increasing FDA Approvals for Drugs
  • 5.5 Impact Analysis

6. Allergy Immunotherapies Market - Global Analysis

  • 6.1 Global Allergy Immunotherapies Market Revenue Forecast And Analysis
  • 6.2 Global Allergy immunotherapies market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Allergy Immunotherapies Market Analysis- by Treatment

  • 7.1 Overview
  • 7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
  • 7.3 Subcutaneous Immunotherapy (SCIT)
    • 7.3.1 Overview
    • 7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
  • 7.4 Sublingual Immunotherapy (SLIT)
    • 7.4.1 Overview
    • 7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

8. Allergy Immunotherapies Market Analysis- by Allergy Type

  • 8.1 Overview
  • 8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
  • 8.3 Allergic Rhinitis
    • 8.3.1 Overview
    • 8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
  • 8.4 Asthma
    • 8.4.1 Overview
    • 8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
  • 8.5 Food Allergy
    • 8.5.1 Overview
    • 8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
  • 8.6 Venom Allergy
    • 8.6.1 Overview
    • 8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
  • 8.7 Other Allergies
    • 8.7.1 Overview
    • 8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

9. Allergy Immunotherapies Market Analysis- by Distribution Channel

  • 9.1 Overview
  • 9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
  • 9.3 Hospital Pharmacy
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
  • 9.4 Retail Pharmacy
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
  • 9.5 Online Pharmacy
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

10. Allergy Immunotherapies Market Analysis And Forecasts To 2027 - Geographical Analysis

  • 10.1 North America: Allergy immunotherapies market
    • 10.1.1 Overview
    • 10.1.2 North America : Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
    • 10.1.3 North America: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.1 Europe: Allergy Immunotherapies Market
    • 10.1.1 Overview
    • 10.1.2 Europe: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 Europe: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 Europe: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 Europe: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
    • 10.1.7 Germany: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 Germany: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 Germany: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 Germany: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 Germany: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 France: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 France: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 France: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 France: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 France: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 UK: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 UK: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 UK: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 UK: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 UK: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.10 Italy: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.1 Italy: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.2 Italy: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.3 Italy: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.4 Italy: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.11 Spain: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.1 Spain: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.2 Spain: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.3 Spain: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.4 Spain: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Asia-Pacific: Allergy Immunotherapies Market
    • 10.2.1 Overview
    • 10.2.2 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Asia-Pacific Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Asia-Pacific Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
    • 10.2.7 China: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 China: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Millkion)
      • 10.2.7.2 China Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 China Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 China Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 Japan: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 Japan: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 Japan Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 Japan Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 Japan Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 India: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 India: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 India Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 India Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 India Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 South Korea: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 South Korea: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 South Korea Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 South Korea Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 South Korea Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Australia: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Australia: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Australia Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Australia Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Australia Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Middle East & Africa: Allergy immunotherapies market
    • 10.3.1 Overview
    • 10.3.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
    • 10.3.3 Middle East and Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
    • 10.3.7 Saudi Arabia: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 Saudi Arabia: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 UAE: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 UAE: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 UAE Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 UAE Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 South Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 South Africa: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 South Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 South Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.4 South and Central America: Allergy immunotherapies market
    • 10.4.1 Overview
    • 10.4.2 South and Central America: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.4.3 South and Central America Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 South and Central America Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 South and Central America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Brazil: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Brazil: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Brazil Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Brazil Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Brazil Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 Argentina: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 Argentina: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 Argentina Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 Argentina Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 Argentina Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Allergy Immunotherapies Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Allergy Immunotherapies Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 ALK-Abello A/S
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 AIMMUNE THERAPEUTICS, INC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 LETIPharma
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Stallergenes Greer
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 HAL Allergy B.V.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Johnson and Johnson Services, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Anergis
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 DBV Technologies
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Dermapharm Holding
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Allergy Therapeutics
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

L

List Of Tables

  • Table 1. North America Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Europe: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Germany: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Germany: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 19. France: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 20. France: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. France: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 22. UK: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 23. UK: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 24. UK: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Italy: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Italy: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Italy: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Spain: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Spain: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Asia-Pacific Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia-Pacific Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 34. China Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. China Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Japan Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Japan Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 40. India Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 41. India Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 42. India Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 43. South Korea Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 45. South Korea Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Australia Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Australia Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Middle East and Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East and Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Middle East and Africa Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Saudi Arabia Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Saudi Arabia Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Saudi Arabia Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 55. UAE Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 56. UAE Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 57. UAE Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Africa Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South and Central America Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Brazil Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Brazil Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Argentina Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Argentina Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 1. Organic Developments Done By Companies
  • Table 2. Inorganic Developments Done By Companies
  • Table 3. Glossary of Terms, Allergy Immunotherapies Market

List Of Figures

  • Figure 1. Allergy Immunotherapies Market Segmentation
  • Figure 2. Allergy Immunotherapies Market - By Geography
  • Figure 3. Global Allergy Immunotherapies Market Overview
  • Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
  • Figure 5. Asia-Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Allergy Immunotherapies Market, By Geography (US$ Million)
  • Figure 7. Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Allergy Immunotherapies Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia-Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Allergy Immunotherapies Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Allergy Immunotherapies Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning of Key Players
  • Figure 18. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
  • Figure 19. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 20. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 21. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
  • Figure 22. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 23. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 24. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 25. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 26. Others Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 27. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
  • Figure 28. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 29. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 30. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
  • Figure 31. North America: Allergy immunotherapies market, by Key Country - Revenue (2019) (USD Million)
  • Figure 32. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
  • Figure 33. North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
  • Figure 34. US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Mexico: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Europe: Allergy Immunotherapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 38. Europe: Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
  • Figure 40. Germany: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. France: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. UK: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Italy: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Spain: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Asia-Pacific: Allergy Immunotherapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
  • Figure 48. China: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Japan: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. India: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. South Korea: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Australia: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Middle East & Africa: Allergy immunotherapies market, by Key Country - Revenue (2019) (USD Million)
  • Figure 54. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
  • Figure 56. Saudi Arabia: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. UAE: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. South Africa: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South and Central America: Allergy immunotherapies market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. South and Central America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
  • Figure 62. Brazil: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Argentina: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries
  • Figure 65. Impact of COVID-19 Pandemic on allergy immunotherapies market in European Countries
  • Figure 66. Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries
  • Figure 67. Impact of COVID-19 Pandemic on allergy immunotherapies market in Rest of the World
  • Figure 68 Growth Strategies Done by the Companies in the Market, (%)
Back to Top